We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
6801
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
HMNF
6802
DELISTED
HMN Financial Inc
HMNF
-74
Closed -$2K
TELL
6803
PUT
DELISTED
Tellurian Inc.
TELL
-124,000
Closed -$1.03M
AAMC
6804
DELISTED
Altisource Asset Management Corp
AAMC
-32
Closed
LKCO
6805
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
-3
Closed -$5K
ASXC
6806
DELISTED
Asensus Surgical, Inc.
ASXC
-6,998
Closed -$56K
AIU
6807
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
0
VBIV
6808
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$0 ﹤0.01%
2
-1,377
-100% -$30.2K
TPHS
6809
DELISTED
Trinity Place Holdings Inc.com
TPHS
$0 ﹤0.01%
1
-107
-99% -$381
AINC
6810
DELISTED
Ashford Inc.
AINC
$0 ﹤0.01%
+1
New +$24
DYNT
6811
DELISTED
Dynatronics Corp
DYNT
$0 ﹤0.01%
+2
New +$8
CSSE
6812
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-33
Closed
WIRE
6813
CALL
DELISTED
Encore Wire Corp
WIRE
-5,100
Closed -$287K
TARO
6814
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-3,732
Closed -$282K
SCX
6815
DELISTED
The L.S. Starrett Company
SCX
-27
Closed
ALPN
6816
DELISTED
Alpine Immune Sciences Inc
ALPN
-2
Closed
CTHR
6817
DELISTED
Charles & Colvard Ltd
CTHR
-7
Closed
STAF
6818
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
-11
Closed -$8K
TRVN
6819
DELISTED
Trevena, Inc.
TRVN
0
TTOO
6820
DELISTED
T2 Biosystems, Inc
TTOO
-13
Closed -$162K
FUV
6821
DELISTED
Arcimoto, Inc. Common Stock
FUV
0
NXTP
6822
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
0
MIXT
6823
DELISTED
MIX TELEMATICS LIMITED
MIXT
-72
Closed -$1K
AYX
6824
PUT
DELISTED
Alteryx Inc
AYX
-45,000
Closed -$4.83M
BKCC
6825
DELISTED
BlackRock Capital Investment Corporation
BKCC
$0 ﹤0.01%
1
-71
-99% -$349

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.